Comparing the therapeutic effectiveness of inhaling single dose of salbutamol with MDI or Easi-Breathe Inhaler in pediatric patients with asthma

洪建国,陆权,张灵恩,李云珠,张庭熹,顾洪亮,方凤,张爱莉
DOI: https://doi.org/10.3969/j.issn.1671-2838.2004.01.004
2004-01-01
Pharmaceutical Care and Research
Abstract:Objective: To compare the therapeutic effectiveness of inhaling single dose of salbutamol with MDI (Ventolin) or Easi-Breathe Inhaler for acute episode in pediatric asthmatic patients. Methods: Multicenter randomized open studies in 140 pediatric patients with acute asthma were done. The patients' ages were between 4-14 years old. The patients were divided into 2 groups, inhaling Easi-Breathe Inhaler or Ventolin once respectively (both contained 200 μg salbutamol). The changes of heart rate, breath rate, wheeze scores and peak expiratory flow (PEF) value were determined before and 5, 15, 30, 120 min after inhalation of salbutamol. Results: General parameters such as age, sex, heart rate, breath rate and PEF between 2 groups were comparable. Comparing pre- and post-treatment values in both groups, the heart rates and breath rates of all patients were lowered, wheeze scores were decreased significantly, PEF were improved significantly. The lowering of heart rates at different time points and improvement of average value of PEF at 120 min in Easi-Breathe Inhaler group were more significant than those in Ventolin group (P<0.05). Conclusion: Patients inhale salbutamol with Easi-Breathe Inhaler can improve the clinical indices and PEF parameter more significantly than Ventolin can.
What problem does this paper attempt to address?